Wed, August 26, 2026
|
CannabisInsightKorea's Cannabis Business & Policy Media

Latest Articles

Curaleaf Formally Launches Aurora Cannabis Takeover Bid — US$4.00 per Share and 45% Premium
Global

Curaleaf Formally Launches Aurora Cannabis Takeover Bid — US$4.00 per Share and 45% Premium

Curaleaf Holdings has formally launched its take-over bid for all Aurora Cannabis common shares. The offer provides about US$4.00 per share, comprising 0.3463 Curaleaf shares plus US$0.75 in cash, representing a 45% premium to Aurora’s unaffected share price as of August 10. The offer remains open until December 1, subject to regulatory approvals and minimum tender conditions.

2026-08-18

Nepal’s Gandaki Province Seeks to Allow Medical and Industrial Cannabis Cultivation
Global

Nepal’s Gandaki Province Seeks to Allow Medical and Industrial Cannabis Cultivation

Gandaki Province Chief Minister Surendraraj Pandey met Prime Minister Balendra Shah to seek federal legal support for opening cannabis cultivation for medical and industrial purposes. The province says it has already enacted a cannabis cultivation law and views regulated commercialization as a potential source of local employment.

2026-08-17

Georgia Proposes USPS and Private-Carrier Delivery for Medical Cannabis — September Hearing and Vote Ahead
Policy & Regulation

Georgia Proposes USPS and Private-Carrier Delivery for Medical Cannabis — September Hearing and Vote Ahead

Georgia’s Medical Cannabis Commission has proposed rules allowing delivery to registered patients, caregivers and healthcare institutions via USPS and private carriers such as FedEx and UPS. The plan requires tracked delivery and a signature from an authorized recipient, with public feedback scheduled for September 16 and an adoption vote planned for September 30.

2026-08-17

CBD Suppresses HER2-Positive Breast Cancer Receptor and Increases Cancer Cell Death in Preclinical Study
R&D & Tech

CBD Suppresses HER2-Positive Breast Cancer Receptor and Increases Cancer Cell Death in Preclinical Study

A preclinical study published in BMC Complementary Medicine reported that CBD reduced expression of a receptor associated with HER2-positive breast cancer and increased cancer-cell death by activating cellular stress pathways. The work also examined potential combination use with trastuzumab, but further validation is needed because the evidence remains at the cell-study stage.

2026-08-16

Top News

Categories